Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tinnitus
Biotech
Tortugas comes out of shell with $106M, 4 ph. 2-stage neuro meds
A pair of Sage veterans has launched a neurology startup armed with $106 million and a clinical-stage pipeline licensed from Eisai and Hansoh.
James Waldron
Apr 21, 2026 10:41am
FDA clears first neuromodulation device to treat tinnitus
Mar 7, 2023 11:00am
Otonomy's phase 2 backup plan fails, prompting new options
Oct 13, 2022 11:05am
Otonomy cuts lead asset loose after phase 2 failure to save cash
Aug 1, 2022 10:23am
